SLNOSoleno Therapeutics Inc
SLNO
Soleno Therapeutics Inc8,210
Mkt Cap
$2.76BVolume
4.97M52W High
$90.3252W Low
$29.43PE Ratio
30.09SLNO Fundamentals
Price
$53.01Prev Close
$52.99Open
$52.9950D MA
$45.52Beta
0.89Avg. Volume
6.86MEPS (Annual)
$0.3909P/B
5.53Rev/Employee
$1.05M$2,172.50
SLNO 8-DAY DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Securities Class Action Alleging Hyperphagia Drug Launch Disruptions - Hagens Berman
SLNO 8-DAY DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Securities Class Action Alleging Hyperphagia Drug Launch Disruptions - Hagens Berman SLNO 8-DAY DEADLINE ALERT...
PR Newswire·7d ago
Are SEM, XOMA, SLNO, KORE Obtaining Fair Deals for their Shareholders?
Are SEM, XOMA, SLNO, KORE Obtaining Fair Deals for their Shareholders? Are SEM, XOMA, SLNO, KORE Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, May 8, 2026 Insiders may stand to...
PR Newswire·9d ago
Soleno Therapeutics Target of Unusually High Options Trading (NASDAQ:SLNO)
Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Stock traders acquired 6,832 call options on the stock. This represents an increase of approximately 92% compared to the typical volume of 3,560 call options...
MarketBeat·12d ago
SLNO DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Today's Lead Plaintiff Deadline in Securities Class Action
SLNO DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Today's Lead Plaintiff Deadline in Securities Class Action SLNO DEADLINE ALERT: Hagens Berman Alerts Soleno...
PR Newswire·13d ago
SLNO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
SLNO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 SLNO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Soleno...
PR Newswire·13d ago
SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities...
PR Newswire·13d ago
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Rating of "Hold" from Analysts
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) have been assigned an average rating of "Hold" from the thirteen analysts that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, nine have given a hold rec...
MarketBeat·13d ago
Deadline Soon: Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz reminds investors of the upcoming May 5, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors...
Business Wire·14d ago
Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO
Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO PR Newswire LOS ANGELES, May 4, 2026 LOS ANGELES, May 4, 2026...
PR Newswire·14d ago
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud...
PR Newswire·14d ago
<
1
2
...
>